Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection.

van de Laar TJ, Matthews GV, Prins M, Danta M.

AIDS. 2010 Jul 31;24(12):1799-812. doi: 10.1097/QAD.0b013e32833c11a5. Review.

PMID:
20601854
[PubMed - indexed for MEDLINE]
2.

Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study.

Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, Monforte Ad, Kirk O, Friis-Moller N, Phillips A, Reiss P, El Sadr W, Pradier C, Worm SW.

AIDS. 2010 Jun 19;24(10):1537-48. doi: 10.1097/QAD.0b013e32833a0918. Erratum in: AIDS. 2011 Mar 27;25(6):883. multiple author names added.

PMID:
20453631
[PubMed - indexed for MEDLINE]
3.

Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort.

Vogel M, Dominguez S, Bhagani S, Azwa A, Page E, Guiguet M, Valantin MA, Katlama C, Rockstroh JK, Nelson M.

Antivir Ther. 2010;15(2):267-79. doi: 10.3851/IMP1501.

PMID:
20386082
[PubMed - indexed for MEDLINE]
4.

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients.

Amorosa VK, Slim J, Mounzer K, Bruno C, Hoffman-Terry M, Dorey-Stein Z, Ferrara T, Kostman JR, Lo Re V 3rd.

Antivir Ther. 2010;15(1):91-9. doi: 10.3851/IMP1492.

PMID:
20167995
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Telbivudine in the treatment of chronic hepatitis B: experience in HIV type-1-infected patients naive for antiretroviral therapy.

Milazzo L, Caramma I, Lai A, Violin M, De Maddalena C, Cesari M, Galli M, Balotta C.

Antivir Ther. 2009;14(6):869-72. doi: 10.3851/1303.

PMID:
19812451
[PubMed - indexed for MEDLINE]
6.

Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons.

Crum-Cianflone N, Collins G, Medina S, Asher D, Campin R, Bavaro M, Hale B, Hames C.

Clin Gastroenterol Hepatol. 2010 Feb;8(2):183-91. doi: 10.1016/j.cgh.2009.09.025. Epub 2009 Oct 2.

PMID:
19800985
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

Mira JA, Gutiérrez-Valencia A, Gil Ide L, Merino D, Rivero A, Ríos-Villegas MJ, Delgado M, González-Serrano M, Collado A, Torres-Tortosa M, Omar M, López-Ruz MA, Macías J, Arponen S, Pineda JA.

Clin Infect Dis. 2009 Oct 15;49(8):e84-91. doi: 10.1086/605677.

PMID:
19772388
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB.

Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.

PMID:
19684573
[PubMed - indexed for MEDLINE]
9.

Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.

Kovari H, Ledergerber B, Peter U, Flepp M, Jost J, Schmid P, Calmy A, Mueller NJ, Muellhaupt B, Weber R; Swiss HIV Cohort Study.

Clin Infect Dis. 2009 Aug 15;49(4):626-35. doi: 10.1086/603559.

PMID:
19589079
[PubMed - indexed for MEDLINE]
Free Article
10.

Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.

Torti C, Lapadula G, Antinori A, Quirino T, Maserati R, Castelnuovo F, Maggiolo F, De Luca A, Paraninfo G, Antonucci F, Migliorino G, Lazzarin A, Di Perri G, Rizzardini G, Esposito R, Carosi G.

Infection. 2009 Jun;37(3):244-9. doi: 10.1007/s15010-008-8010-6. Epub 2009 May 26.

PMID:
19471856
[PubMed - indexed for MEDLINE]
11.

Hepatitis B and human immunodeficiency virus coinfection.

Thio CL.

Hepatology. 2009 May;49(5 Suppl):S138-45. doi: 10.1002/hep.22883.

PMID:
19399813
[PubMed - indexed for MEDLINE]
12.

Diagnosis, management, and treatment of hepatitis C: an update.

Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases.

Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759. No abstract available.

PMID:
19330875
[PubMed - indexed for MEDLINE]
13.

Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.

Salmon-Ceron D, Rosenthal E, Lewden C, Bouteloup V, May T, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Cacoub P, Chêne G; ANRS EN19 Mortalité Study Group and Mortavic.

J Hepatol. 2009 Apr;50(4):736-45. doi: 10.1016/j.jhep.2008.11.018. Epub 2009 Jan 3.

PMID:
19231018
[PubMed - indexed for MEDLINE]
14.

Nonalcoholic fatty liver disease among HIV-infected persons.

Crum-Cianflone N, Dilay A, Collins G, Asher D, Campin R, Medina S, Goodman Z, Parker R, Lifson A, Capozza T, Bavaro M, Hale B, Hames C.

J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):464-73. doi: 10.1097/QAI.0b013e318198a88a.

PMID:
19225402
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

HIV-related liver disease: ARV drugs, coinfection, and other risk factors.

Puoti M, Nasta P, Gatti F, Matti A, Prestini K, Biasi L, Carosi G.

J Int Assoc Physicians AIDS Care (Chic). 2009 Jan-Feb;8(1):30-42. doi: 10.1177/1545109708330906. Epub 2009 Feb 11. Review.

PMID:
19211929
[PubMed - indexed for MEDLINE]
16.

Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.

Chaudhry AA, Sulkowski MS, Chander G, Moore RD.

HIV Med. 2009 Mar;10(3):133-42. doi: 10.1111/j.1468-1293.2008.00662.x. Epub 2008 Dec 20.

PMID:
19207596
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Abacavir does not influence the rate of virological response in HIV-HCV-coinfected patients treated with pegylated interferon and weight-adjusted ribavirin.

Laufer N, Laguno M, Perez I, Cifuentes C, Murillas J, Vidal F, Bonet L, Veloso S, Gatell JM, Mallolas J.

Antivir Ther. 2008;13(7):953-7.

PMID:
19043930
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H.

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1315-41; quiz 1286. doi: 10.1016/j.cgh.2008.08.021. Epub 2008 Aug 23. Review.

PMID:
18845489
[PubMed - indexed for MEDLINE]
19.

Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons.

Kim HN, Harrington RD, Van Rompaey SE, Kitahata MM.

Int J STD AIDS. 2008 Sep;19(9):600-4. doi: 10.1258/ijsa.2007.007197.

PMID:
18725550
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir.

Vispo E, Barreiro P, Pineda JA, Mira JA, Maida I, Martín-Carbonero L, Rodríguez-Nóvoa S, Santos I, López-Cortes LF, Merino D, Rivero A, Soriano V.

Antivir Ther. 2008;13(3):429-37.

PMID:
18572756
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk